Nitric Oxide Cuts Kidney Injury After Long Cardiac Surgery

Share this content:
Nitric Oxide Cuts Kidney Injury After Long Cardiac Surgery
Nitric Oxide Cuts Kidney Injury After Long Cardiac Surgery

FRIDAY, June 29, 2018 (HealthDay News) -- Nitric oxide gas may lead to a reduction in the incidence of acute kidney injury and an improvement in long-term kidney function in patients undergoing multiple valve replacement and prolonged cardiopulmonary bypass, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

Chong Lei, M.D., Ph.D., from the Fourth Military Medical University in China, and colleagues assessed whether administration of nitric oxide reduces the incidence of postoperative acute kidney injury and improves long-term kidney outcomes among 244 patients undergoing elective, multivalve replacement surgery (mostly due to rheumatic fever) requiring prolonged cardiopulmonary bypass. The patients were randomized to receive either nitric oxide or nitrogen (control).

The researchers found that oxidation of ferrous plasma oxyhemoglobin to ferric methemoglobin was associated with reduced postoperative acute kidney injury from 64 percent in the control group to 50 percent in the treatment group. Transition to stage 3 chronic kidney disease was reduced at 90 days from 33 percent in the control group to 21 percent in the treatment group and at one year from 31 percent to 18 percent. In addition, nitric oxide treatment reduced the overall major adverse kidney events at 30 days (relative risk, 0.4; 95 percent confidence interval, 0.18 to 0.92; P = 0.016), 90 days (relative risk, 0.4; 95 percent confidence interval, 0.17 to 0.92; P = 0.015), and one year (relative risk, 0.47; 95 percent confidence interval, 0.2 to 1.1; P = 0.041).

"These results should be assessed in non-Chinese patients without rheumatic fever," write the authors.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »